Publications

by members of

Pennsylvania State University → Department of Health Policy and Administration

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.

---

| Working papers | Journal articles | Chapters |

Working papers

Undated

1. Jelena Zurovac & Randy Brown & Kieron Dey & Jodi Segal & David Vanness, undated, "A New Tool for Rapid-Cycle Comparative Effectiveness Research: The Promise of Orthogonal Design," Mathematica Policy Research Reports, Mathematica Policy Research, number 3c03d22d6ea8479c81ce18b97.

---

Journal articles

2026

1. Laura Vallejo-Torres & Laura C. Edney & Oscar Espinosa & Jonathan Karnon & Francesco Longo & Mike Paulden & Daniel Howdon & David J. Vanness, 2026, "Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative," Applied Health Economics and Health Policy, Springer, volume 24, issue 2, pages 243-246, March, DOI: 10.1007/s40258-025-01026-y.

2023

1. Kumar Mukherjee & Necdet B. Gunsoy & Rita M. Kristy & Joseph C. Cappelleri & Jessica Roydhouse & Judith J. Stephenson & David J. Vanness & Sujith Ramachandran & Nneka C. Onwudiwe & Sri Ram Pentakota &, 2023, "Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations," PharmacoEconomics, Springer, volume 41, issue 12, pages 1589-1601, December, DOI: 10.1007/s40273-023-01297-0.

2021

1. Andrew H. Briggs & Daniel A. Goldstein & Erin Kirwin & Rachel Meacock & Ankur Pandya & David J. Vanness & Torbjørn Wisløff, 2021, "Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19," Health Economics, John Wiley & Sons, Ltd., volume 30, issue 3, pages 699-707, March, DOI: 10.1002/hec.4208.

2020

1. Lih-Wen Mau & Jaime M. Preussler & Linda J. Burns & Susan Leppke & Navneet S. Majhail & Christa L. Meyer & Tatenda Mupfudze & Wael Saber & Patricia Steinert & David J. Vanness, 2020, "Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach," PharmacoEconomics, Springer, volume 38, issue 5, pages 515-526, May, DOI: 10.1007/s40273-020-00891-w.

2006

1. Flynn, Kathryn E. & Smith, Maureen A. & Vanness, David, 2006, "A typology of preferences for participation in healthcare decision making," Social Science & Medicine, Elsevier, volume 63, issue 5, pages 1158-1169, September.

2003

1. David J. Vanness, 2003, "A structural econometric model of family valuation and choice of employer‐sponsored health insurance in the United States," Health Economics, John Wiley & Sons, Ltd., volume 12, issue 9, pages 771-790, September, DOI: 10.1002/hec.837.

2002

1. David J. Vanness & W. Ray Kim, 2002, "Bayesian estimation, simulation and uncertainty analysis: the cost‐effectiveness of ganciclovir prophylaxis in liver transplantation," Health Economics, John Wiley & Sons, Ltd., volume 11, issue 6, pages 551-566, September, DOI: 10.1002/hec.739.

---

Chapters

2012

1. David J. Vanness & John Mullahy, 2012, "Moving Beyond Mean-based Evaluation of Health Care," Chapters, Edward Elgar Publishing, chapter 52, in: Andrew M. Jones, "The Elgar Companion to Health Economics, Second Edition".

2006

1. David J. Vanness & John Mullahy, 2006, "Perspectives on Mean-based Evaluation of Health Care," Chapters, Edward Elgar Publishing, chapter 49, in: Andrew M. Jones, "The Elgar Companion to Health Economics".

---